Nemes Rush Group’s Pfizer PFE Stock Holding History

Nemes Rush Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$254K	Sell	9,049 -635	-7%	-$16.9K	0.02%	191
2025 Q4	$241K	Sell	9,684 -3,963	-29%	-$99.9K	0.02%	195
2025 Q3	$348K	Sell	13,647 -14,897	-52%	-$368K	0.03%	150
2025 Q2	$692K	Sell	28,544 -86,066	-75%	-$2.01M	0.08%	109
2025 Q1	$2.9M	Sell	114,610 -12,251	-10%	-$321K	0.37%	56
2024 Q4	$3.37M	Buy	126,861 +10,189	+9%	+$276K	0.42%	53
2024 Q3	$3.24M	Sell	116,672 -24,358	-17%	-$711K	0.47%	48
2024 Q2	$3.95M	Buy	141,030 +23,281	+20%	+$641K	0.54%	45
2024 Q1	$3.27M	Buy	117,749 +47,622	+68%	+$1.32M	0.47%	48
2023 Q4	$2.02M	Sell	70,127 -3,455	-5%	-$104K	0.33%	58
2023 Q3	$2.44M	Buy	73,582 +2,918	+4%	+$103K	0.44%	53
2023 Q2	$2.59M	Buy	+70,664	New	+$2.75M	0.46%	54

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Nemes Rush Group's PFE Position: Q1 2026 in Review

Nemes Rush Group reduced its Pfizer (PFE) stake by 6.6% in Q1 2026, selling an estimated $16.9K and leaving 9,049 shares worth $254K. The position accounts for 0.02% of the portfolio, ranked #191.

Nemes Rush Group first reported a position in PFE in Q2 2023 and has held it in 12 quarters since. The position peaked at $3.95M in Q2 2024. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Nemes Rush Group held 9,049 shares of Pfizer worth $254K as of Q1 2026.
Nemes Rush Group sold 635 Pfizer shares in Q1 2026, an estimated $16.9K.
Pfizer made up 0.02% of Nemes Rush Group's portfolio in Q1 2026, its #191 holding.
Nemes Rush Group first reported a position in Pfizer in Q2 2023 and has held it in 12 quarters since.
Nemes Rush Group's Pfizer position peaked at $3.95M in Q2 2024.
2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.